Source link : https://www.newshealth.biz/health-news/tavr-cerebral-embolic-protection-trial-stopped-prematurely/
LONDON — Two years after the large multinational PROTECTED TAVR trial failed to associate a cerebral embolic protection (CEP) device with significant protection from stroke in patients undergoing transcatheter aortic valve replacement (TAVR), a second multicenter trial with a similar design was stopped at an interim analysis for futility. The Data Monitoring Committee (DMC) of […]
Author : News Health
Publish date : 2024-11-12 09:19:33
Copyright for syndicated content belongs to the linked Source.